18F-DCFPyL PET/CT in Men with Prostate Cancer
18F-DCFPyL PET/CT in Men with Prostate Cancer
Sponsor: NA
Enrolling: Male Patients Only
IRB Number: AAAS1862
U.S. Govt. ID: NCT03824275
Contact: Research Nurse Navigator: 212-342-5162 / cancerclinicaltrials@cumc.columbia.edu
Additional Study Information: The purpose of this study is to see if 18FDCFPyL (PyL) PET/CT scans are able to find prostate cancer tumors. PyL is a radioactive drug (tracer) that targets prostate specific membrane antigen (PSMA). Because PSMA is a protein found mostly on the surface of prostate cancer cells, we are testing to see if PyL will be able to correctly identify prostate cancer. We will also see if we can detect prostate cancer tumor DNA (ctDNA) and cell particles (exosomes) in the blood. We hope that this may one day lead to better tests to evaluate patients with prostate cancer.
This study is closed
Mark Stein, MD
Do You Qualify?
Are you a man of at least 18 years of age? Yes No
Do you have confirmed prostate cancer? Yes No
Are you able to perform everyday tasks independently? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Research Nurse Navigator